Radiopharm Theranostics RADX
NASDAQ RADX
$0.88 -0.07 (-7.70%)
At close: Nov 9, 2026 · 4:00 PM EST

Radiopharm Theranostics (RADX) Shares Outstanding (Entity) (2023 - 2026)

Updated

Radiopharm Theranostics (RADX) recorded Shares Outstanding (Entity) of 2.36 billion in fiscal Q4 2025 (quarter ended Jun 30, 2025), up 413.7% from 460.37 million a year earlier.

Analysis

Radiopharm Theranostics (RADX) Shares Outstanding (Entity) (2023 - 2026) Analysis & Trends

  • Across earlier fiscal years, Shares Outstanding (Entity) came in at 460.37 million in FY2024 (+35.7%) and 339.31 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 940.75 Mn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 2.41 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 1.77 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 2.47 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 540.90 Mn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 1.24 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 5.70 Bn
10 Radiopharm Theranostics 2.70 Bn 2.62 Bn - 3.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.81 Mn
Jun 30, 2025 7.88 Mn
Jun 30, 2024 1.29 Mn
Jun 30, 2023 1.02 Mn
API Access

Radiopharm Theranostics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=RADX&period=max&api_key=YOUR_API_KEY